BioPharma Services

We offer a robust molecular diagnostic test menu, as well as provide contract services at all stages of biopharmaceutical product development, including analytical validation, clinical validation with the NYS CLEP, quality control and process control services, and clinical trial testing. Through Labcorp Drug Development, we can also incorporate our tests into larger clinical research studies.

Checkpoint Inhibition

CAR-T Cell Therapy

Targeted Therapy

Cancer Vaccines

Clinical Solutions

Clinical Reporting

Genomic & Immune Profiling

  • FFPE
  • 900+ Markers
  • 523 Genes
  • SNVs & Indels
  • 59 Copy Number
  • 55 Fusions (RNAseq)
  • PD-L1, TMB, MSI
  • 64 Immune Expression
  • TCRs, TILs, NK
  • Cancer Testis Antigens
  • View OmniSeq INSIGHTSM Gene List

Regulatory and Licensing

BioPharma Solutions

Genomic & Immune Profiling

  • FFPE
  • 900+ Markers
  • 523 Genes
  • SNVs & Indels
  • 59 Copy Number
  • 55 Fusions (RNAseq)
  • PD-L1, TMB, MSI
  • 64 Immune Expression
  • TCRs, TILs, NK
  • Cancer Testis Antigens
  • View OmniSeq INSIGHTSM Gene List

Genomic Profiling

Immune Gene Expression

  • FFPE
  • 395 Immune Markers
  • 64 Clinically Validated
  • TCRs, TILs, NK
  • Cancer Testis Antigens
  • Checkpoint Pathway
  • Cytokine Signaling
  • Lymphocyte Presentation
  • Tumor Characterization
  • View Immune Profiling Gene List 

TCRβ Repertoire

  • TCR-β-LR Assay (RNA)
    FF / PBMC / Blood
    CDR1, CDR2, CDR3
  • TCR-β-SR Assay
    (RNA + DNA)
    FFPE / FF/ PBMC
    cfDNA / DNA / T-cells
    CDR3

PD-L1 IHC

  • FFPE
  • Ventana SP142
  • Dako 22C3

Transcriptome Sequencing

  • FFPE / PBMC / Blood
  • RNAseq
  • Global Transcript Expression
  • Differential RNA Expression
  • Neoantigen Prediction

Genome / Exome Sequencing

  • FFPE / PBMC / Blood
  • DNAseq NGS
  • 22,000 Genes

Data Solutions

Bioinformatic Analysis

  • Biomarker Discovery
  • Biomarker Prevalence
  • Clinical Trial Design
  • Biomarker Strategy

Retrospective Clinical Cohorts

  • Clinical Cases
  • >15,000 Tumor Profiles
  • Genomic + Immune
  • 40+ Cancer Types

Prospective Clinical Testing

  • Clinical Trial Enrichment
  • Just-In-Time Recruitment
  • Peer-to-Peer
  • Physician Outreach
  • Lab-Alert Programs

Biomarker Signatures

  • Tumor Inflammation
  • Cell Proliferation
  • Bi-Specific Analysis

From providing clinical testing services to clinical laboratory assay development, OmniSeq® is here to help you reach your clinical and research goals.

To find out more about our services or if you are interested in partnering with us, please give us a call at 1-800-781-1259 or email us at info@omniseq.com.